Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Bioorganic Chemistry|January 21, 2021
Discovery of novel indole derivatives that inhibit NEDDylation and MAPK pathways against gastric cancer MGC803 cellsDong-Jun Fu, Xin-Xin Cui, Ting Zhu, et al.European Journal of Medicinal Chemistry|July 24, 2024
Strategies that regulate Hippo signaling pathway for novel anticancer therapeuticsNa Li, Yun-He Liu, Ji Wu, et al.Bioorganic & Medicinal Chemistry Letters|November 20, 2019
Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cellsJian Song, Xin-Xin Cui, Bo-Wen Wu, et al.Molecules (Basel, Switzerland)|February 11, 2023
A Review of the Regulatory Mechanisms of N-Myc on Cell CycleHong-Li Li, Lu-Lu Dong, Min-Jie Jin, et al.European Journal of Medicinal Chemistry|July 24, 2023
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapyWei-Xin Zhang, Jiao Huang, Xin-Yi Tian, et al.Molecules (Basel, Switzerland)|July 19, 2021
Discovery of Novel Diarylamide <i>N</i>-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer ActivityXu Liu, Xiao-Jing Pang, Yuan Liu, et al.European Journal of Medicinal Chemistry|December 31, 2021
Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activitiesYa-Xin Sun, Jian Song, Li-Jun Kong, et al.European Journal of Medicinal Chemistry|December 27, 2023
Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activitiesXin-Yi Tian, Wei-Xin Zhang, Xiao-Yu Chen, et al.European Journal of Medicinal Chemistry|May 23, 2022
Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activitiesJian Song, Yong-Feng Guan, Wen-Bo Liu, et al.European Journal of Medicinal Chemistry|July 19, 2024
Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degradersXiao Wang, Na Li, Yun-He Liu, et al.Pageof 7